Dr Marco Traub
Neuroscientist
Dr. Marco Traub is a Neuroscientist who gained considerable experience in a number of stem cell expert and management and educational roles over the past 20 years. He acts as CEO of the Trans European Stem Cell Therapy Consortium (TESCT) and as an EU-Commission expert in FP7 and the Innovative Medicine Initiative (IMI JU) 2018, which is a public private partnership between the European Commission (FP6/FP7/ Horizon 2020, Health and Life sciences) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) and COST framework for Switzerland.
While in Switzerland and UK, he specialised in Biotechnology, with a focus on PCR technology and peptide synthesis and their GMP production. In the same period he was Assistant Professor at the Medical School at the University of Kansas City. There he was involved in research projects and teaching neuro-anatomy and opiate receptor pharmacology as well as in molecular medicine.
His current technical expertise is focused on cell banking and IPS cell technology with gene editing. In addition this he has participated successfully in grant applications and (EU) funded projects and has received Exploratory and Research awards from the EU Commission and Swiss Government due to following the selected projects:
"Development of ultra-sensitive diagnostic assays for the detection of genetic disorders, infections and for monitoring the therapeutic success following gene therapy”
and
“Establishment of novel targets for risk assessment and monitoring of xenogeneic infections in the course of animal to human transplantation”.
An invited speaker and adviser to the world congress for freedom of scientific research and the “Associazione Luca Coscioni” in cooperation with the permanent mission of Italy to the United Nations and International organisations in Geneva 2016. An Invited Chair in the 5th meeting of the world congress for freedom of scientific research European parliament, Brussels 2018 and advisor to “SCIENCE FOR DEMOCRACY: towards the human right to science”. The current research topic is focused towards neuro-active active compounds e.g. THC and methadone paving the way for advanced therapies in the course of PD and depression and autism and cancer. Furthermore he is in charge for the early intervention and support in the field of Scientific literacy.